quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:31:00·71d
PRRelease
AbbVie Inc. logo
ArriVent BioPharma Inc. logo
Black Diamond Therapeutics Inc. logo
+10

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

ABBV· AbbVie Inc.AVBP· ArriVent BioPharma Inc.BDTX· Black Diamond Therapeutics Inc.BMY· Bristol-Myers Squibb CompanyCGEM· Cullinan Therapeutics Inc.GNPX· Genprex Inc.
Health Care
Original source

Companies

  • ABBV
    AbbVie Inc.
    Health Care
  • AVBP
    ArriVent BioPharma Inc.
    Health Care
  • BDTX
    Black Diamond Therapeutics Inc.
    Health Care
  • BMY
    Bristol-Myers Squibb Company
    Health Care
  • CGEM
    Cullinan Therapeutics Inc.
    Health Care
  • GNPX
    Genprex Inc.
    Health Care
  • JNJ
    Johnson & Johnson
    Health Care
  • LLY
    Eli Lilly and Company
    Health Care
  • LTRN
    Lantern Pharma Inc.
    Health Care
  • MRK
    Merck & Company Inc.
    Health Care
  • MRUS
    Merus N.V.
    Health Care
  • PFE
    Pfizer Inc.
    Health Care
  • SMMT
    Summit Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Apr 21ABBVUpdateCanaccord Genuity$262.00
  • Apr 8SMMTUpdateStifel$45.00
  • Apr 8JNJUpdateTD Cowen$250.00
  • Mar 17LLYUpdateHSBC Securities$850.00
  • Mar 16SMMTUpdateJefferies$15.00
  • Mar 12AVBPUpdateBTIG Research$42.00

Related

  • PR8h
    AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
  • PR16h
    Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration
  • PR17h
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • PR1d
    Pfizer Declares Second-Quarter 2026 Dividend
  • SEC1d
    SEC Form 10-Q filed by Johnson & Johnson
  • PR1d
    AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
  • PR1d
    IMAAVY® (nipocalimab-aahu) shows over two years of sustained disease control in a broad population with generalized myasthenia gravis (gMG)
  • PR1d
    Merck and Google Cloud Partner to Accelerate Agentic AI Enterprise Transformation
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022